CA2059602A1 - Pour-on formulation for the administration of anthelmintics - Google Patents

Pour-on formulation for the administration of anthelmintics

Info

Publication number
CA2059602A1
CA2059602A1 CA002059602A CA2059602A CA2059602A1 CA 2059602 A1 CA2059602 A1 CA 2059602A1 CA 002059602 A CA002059602 A CA 002059602A CA 2059602 A CA2059602 A CA 2059602A CA 2059602 A1 CA2059602 A1 CA 2059602A1
Authority
CA
Canada
Prior art keywords
weight
fenbendazole
pour
agent
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002059602A
Other languages
French (fr)
Inventor
Hans Roechling
Dieter Duewel
Karlheinrich Schmid
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2059602A1 publication Critical patent/CA2059602A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Abstract of the disclosure A pour-on formulation for the administration of anthel-mintics Fine-particle dispersions of benzimidazole or benzothia-zole derivatives or probenzimidazoles with anthelmintic activity in water in which penetration-promoting oils are emulsified, or fine-particle dispersions of the said active ingredients in penetration-promoting oils as pour on formulation, a process for the preparation thereof and processes for controlling helminths in livestock.

The novel formulations have high activity against parasi-tizing nematodes and their stages in the digestive tract and in tissues.

Description

-- 2~6~2 ~OECHST ARTI~N&E5~LLSC~AFT HO~ 91~F 016 Dr. WS~Le Description A pour-on formulation for the administration o anthel-min~ics The present in~ention relates to pour-on formulations, to a process for the preparation thereof and to the use thereof for controlling helmin~h~ in live~tock.

A number of publications descrlbe the pour-on, also ~pot-on, proce~ for controlling ectoparasites in livestock:
Journ. Econ. Entomology, 53, (1960), pp. 814-817, ~P-A-045424, DE-A-3208334, EP-A-120286, EP A-311180. ~his entails the liquid preparation of an insecticidal/acari-cidal agent being administered by pouring on along the dorsal line from the withers to the tailhead of agricul-tural productive livestock, especially cattle. The nature of the formulations must be such that spreading achieves an action against the pests on the entire animal body.

Pour-on formulations ~hich are also active against ; endoparasites when admini~tered in the way described must transport ~ystemically active age~ts through the animal skin into the bloodstream. Preparations of thi6 type are known for levami~ole (EP-A-1376~7~ D~-A-3212735, DE-A-2614841) and for ivermectin (EP 89302680). Both compounds are readily ~oluble in water and solvents so that penetration of the animal skin can be achieved 2S relatively ea~ily.

A very important group of agents for controlling endoparasitic helminths are suitably substituted banzimidazole and benxothiazole derivativas, as well as the gxoup of so-called prohenzimidazoles (compounds which 30 can be metabolized to benzimidazole derivatives with anthelmintic activity), like the compound~ of the for-mulae I to III listed hereinafter:

- .

: ~ , ; :. . .
.
, ..

~9~0~
. - 2 -.
2~, N
\~ R 1 ` ~ N
H
Ia) in which Rl i8 methoxycarbonylamino and R2 i~ n-propylmercap~o (albendazo]Le)~ phenylmercapto (fenbendazole), phenyl~ulfinyl (oxfendazole), benzoyl (mebendazole3, p-~luorobenzoyl (flu-bendazole), p-~luorophenylsulfonyloxy (luxa-bendazolej~cyclopropylcarbonyl(cyclobendazol~) t butyl (parbendazole), n-propoxy ~oxibendazole) ::10 ~ or ~ (carbendaæim); or Ib) in which iL~ 4-thiazolyl and 2 i~ :H (thiabendazole) or isopr~poxycarbonylamino (cambendazole).

: 15 ~ R~3 tII) :in~::which : : : : :
R3 is methoa~carbonylamino and R4 iB n-propo~y ( tioxidazole ~ .

~III) in which ~.

`" 2 0 ~ -- 3 R5 is -N-C(NHCOOCH3)2, R6 is -NHCOCH20CH3, R7 is phenylmercapto and R8 i~ H ~febantel); or Rs is N C ~ NHCH2CH2S3H

R5 is NO2, R7 is H and R8 iB n-propylmercapto : 5 (netobimin); or R5 and R8 are each -NXCSNH-COOC2H~, ~' and R8 are each H (thiophanate).

These agents are sparingly ~oluble substances so that it has not hitherto been possible to prepare pour-Qn for-: 10 mulations in suitable ~olvents. Thi~ is why it ha~
hitherto been necessary to carry out a treatment o~
~ helminth-infected livestock (for example cattle or sheep) . :
: by the so-called drench proces~ or orally with the ~id of ; a bolus.

The use of th pour-on process would be consi.derably more economic for the treatment of large herds be~ause it is, inter alia, considerabIy les~ time-consuming and labor intensive. It i~ not necessary to immobilizs the live-~:~ stock, ~here is less risk to the treating person from -~: 20 defensive movement of the livestock, and thare i~ less tres~0 especially for livestQck unused to being handled.

It has been found, surprisingly, that fine-parkicle dispersions (suspenslons) o~ the said benzimidazoles, banzothiazoles and prQbenzimidazoles with anthelmintic ~ 25 activity are able, when suitable pene~ration-promoting : oils are u~ed and admini~tration i~ by the pour on process, to enter the body by the tran~dermal route, whera they display a good effect against nematodas and their stages parasitizing the dige~tive tract and tissues. To do this, it is merely necessary, when the do~age is suitable, to apply a stxip of the ~ormulation to ~he back of the livestock.
~: .
.

- - . . i , .

- 2 ~ 2 ~he invention therefore relates ~o preparations which have anthelmintic activity and which contain a~ active ingredient at least one henzimida~ole, b~nzothiazole or probenzimidazole with anthelmintic activity in fine-particle dispersion in a penetration-promoting agent. It is also possible to use mixtures of the said active : ingredients.

The particles of active ingredient in the~e disper~ion~
should have a parti~le ~ize from 0.05 to about 30 ~m, pre~erably from 0.5 to lU ~m.

Penetration-promoting oils which can be employecl are triglycerides of saturat2d vegetable fatty acids, for :~ example Miglyol 812~, triglycercol dii~ostearate or esters ~: of long-chain acid6, ~uch a~, for ~xample, oleyl oleate, : 15 isopropyl myristate, i~opropyl palmitate, 2-ethylhex~l palmitate r i~ooctyl stearate, isopropyl stearate, hexyl laurate or di n-butyl adipate; a~ w811 a~ long-chain alcohol~ such ~, for example, hexylalcohol, octyl al-cohol, decyl alcohol, oleyl alcoho~, 2-oetyldodecanol, 2-hexyldecanol or 2~octyldecanol. All the penetration-promoting agent~ can be employed alone or mixed with one another. A particularly good penetration-promoting ef~ect is produced by long-chain alcohol~ and, among the~e, in particular the 2-alkyl-substituted alcohols~ ~he oil~ are employed in contents of 5-95~ by weight, preferably from 30 to 90% by w~ight. The fine-particle actlve ingredie~ts can al80 be dispersed in water in which penetration-promoting oils are emulsified, in which ca~e ~he water content of the~e di~persions can be up ~o 50% by weight, preferably up to 30% by weight.

The following can be used as emulsifiers and wetting agent~:
alkylaryl polyglycol ether a}eohols, for example ~rriton types, ~Sapogena T, Arkopal t~pes; ~atty alcohol poly-3S glycol ether3 such as, for example, Emulsogen M, A and :

, : :

~05961D2 MS12, ~Genapol X-080,o al~yl diglycol ether ~ul$ate N~
salts such as, for example, Genapol LRO; Na lauryl sul~ate, for example ~Texapon R12; ethoxylated CaBtOr oil types ~uch as, for e~ample, ~Emulsogen ~; C3 to C2~-alcohol propylene oxide block alko~ylate~ such a~, for example, Hoe S 3510 and HOE S 2436, xylenol ethoxylate with 4-5 EO, tri~tyrylph2nol polyglycol ether and tri-styrylphenol polyglycol ether pho~phates such asy for example, ~oe S 3474 and Hoe S 3775r alkylaryl~ulfonic acid calcium and sodium salt~ such as, for example, phenylsulfonate Ca(70), sorbitan fa~ty acid esters, for example Span 60 and 80, polyoxyethylene ~orbitan fatty acld esters, for example l~een 60 and 80 and polyoxyethy-lene stearates, for e~ample ~Nyrj 45, 4g and 51.
Dispersant~ w~ich csn be employed are, inter alia:
ligninsulfonates such as, for ex~mple, ~Vani~perse CB and polymerized arylalkylsulfonlc acid~ such as, for example, ~Darvan No. 3, magn sium and aluminum stearates, especially al~minum monostearate. The auxiliarie~ are employed in contents of 0.5 to 30%, preferably from 1 to 10%, by weight.

Silicone antifoam S~2 can be used, inter alia, as anti- :
foam agent.

~he content of active ingredient in the formulation can be 1 to 60% by weight, preferably 5 20~ by weight.
::
The invention also relates to a process for the prepara-tion of a pour-on formulation, which compri~e~ converting the fine-particle active ingredients into a suitable : administration form.

Various proces~2s can be used to prepare the pour-on ~ormulation~/ as follows:

1. The active ingredient from the clas~ of benzimida-zoles, benzothiazoles or probenzimidazoles is finely ground în water with the addition of wetting agents -~
. , , . ~ .
,: . ~ , , . . .. : :
- . .

-` 2~9~2 - 6 ~
and using a bead mill; the penetration~ promoting oil i8 mi~ed wi~h an emulsifier and emulslfied in the aqueous disper~ion of active ingredient. ~his results in a ~u~po-emulsion in which the active ingredient i8 suspended as fine particles in water and in which the penetration-promoting oil i8 emulsified.

2. The active ingredient i~ ground in a penetration-promoting oil with the addition o~ wetting agent~
and disper~ants and u~ing a bead mlll.
3. When the substance with anthelmintic activity has the particle finenes described, wheth~r by the u~e of suitab1e precipitation methods in the preparation or by u~e of dry milling, for example~ it can also be homogenized in water after addition of wetting agents and dispersants without wet millin~. Tha oil is then emalsi~ied in the aqueou~ di~persion as described under 1. An air ~et mill such as, for ; example, a spiral ~et mill can be used for the dry milling of the active ingredients.
4. When the active ingredient has sufficient particle : fineness as described under 3., it can also be , , dispersQd in the penetration-promoting oil without wet milling when suitable wetting agent~ and dis-: ~ 25 persants, and ~uitable mixing and stirring equip-ment, are used.
;
~he following descriptions of preparationæ carried out with ~enbendazole by way ~f example are intended to explain processes 1. to 4. without restricting the invention thereto.

; A PE 075 stirrer mill from Netzsch-~einmahltechnik GmbH
was used for ~et milling o~ ~he active ingredients.

An ~ltra ~urra~ apparatus from Janke and Kunkel was . . , . , ~ , , , , .

~- ,, , , ; : , ~
: : : . : . ~ ::

205~2 employed :Eor the homogenization with a high-speed stirrer .

Example 1 7 . 5% strength fenbendazole pour-on formulation S Fenbendazole is milled together with wetting agents and dispexsants and with an antifoam in a stirrex mill until 8596 of the particles are smaller than 1 ~m, milling for about 4 hours being necessary for this. Glass beads with a diameter of 2 mm are used, the amount of ~hem present being twice as high as that of the active ingredient ~enbendaæole:

1. fenbendazole dispersion 40.00% by weight fenbendazole, 99.8% pu:re A.004 by weight ~enapol X-080 7.00% by weight ~Vanisperse CB
.00~ by weight 0Darvan No. 3 1~00% by weight silicone antifoam SE2 46.00% by weight water A solution of the emulsifier~ in the oils is pre-: 20 pared by stirring and heating ~ently at 35-40Cs 2. emulsi:Eier ~olution 9.3896 by weight phenylsulfonate Ca~70) 4 . 37~ by weight Hoe S 3510 6 . 25~ by weight Hoe S 3474-2 40.00~ by weight 2-octyldodecanol 21.25% by weight ~Miglyol 812 18.75% by weight of enbendazole dispersio~ ~1.) are added to the stirred emulsifier solution. ~he result ls a su~po-emulsion which can easily be poured, is stable on storage and can be used as pour-on .

2 ~

preparation.

Example 2 - 10~ strength fenbendazole pour-on formul~tion The ~ollowing mixture is ground in a ~tirrer mill using glass beads (diameter 2 mm~ until 80~ o the particles are smaller than 1 ~m:

1. fenbendazole di~persion 35.00% by weight fenbenda ole, techn. 99.8% p~re 4.00~ by weight Genapol X-080 7.00% by weight banisperse CB
2.00% by weight Darvan Mo. 3 1.00% by weighk ~Silicone antifoam SE2 51.00% by weight water ~ Then a solution of the emulsifiers in the oils i8 pre-: 15 pared by ~tirring and heating at 35-40~C:

2. emulsifier solution .38% by weight phenylsulfonate Ca (70 :4.37% by weight Hoe S 3510 6.25% by weight Hoa S 3474-2 30.00% by weight 2-octyldodecanol : 21.40~ by wei~ht ~iglyol 812 28.6~ by weighk of the aqueou3 fenbendazole di~per ~ion (1.) iB added 810wly to this emul~ifier 901u-tion wikh stirring. ~his re~ults in a fenbendazole pour-on formulation which can easily be poured and is stable on ~torage.

Example 3 10% ~trength fenbendazole pour-on ormulation '~
A formulation of khe following compo~ition i8 prepared as : : - ...................... .
:: :; . . :

-" 2~96~
_ 9 _ described in Example~ 1 and 2:

10.02~ by weight fenbenda~ol~, 99.8~ pure - 1.00~ by weight ~Genapol X-080 1.75% by weight ~Vanisperse C~
0.50% by weight ~Darvan No. 3 0.25~ by weight silicone antifoam SE2 11.48% by w~ight water 9.37~ by weight phenylsulfonate Ca (70) 6.25% by weight Hoe S 3474-2 4.38% by weight Hoe S 3510 35.00~ by wei~ht 2-octyldodecanol 20.00% by ~eight ~Miglyol 812 The formulation can easily he poured and is ~table on : s~orage with respect to homogeneity and stabili~.y of active in~redient.

; Example 4 ::
A fenbenda~ole dispersion is milled in a bead mill for 4 hours as described in Examples 1 and 2 until 82% of the particles are ~maller than 1 ~m-: 20 1. fenbendazole di~persion 40.00% by weight fenbendaæole, techn. ~9.8% pure 4.00% by weight Genapol LRO pa~te 56.00% by weight water Then a solution of the emulsi~iers in the mixture of 2-octyldodecanol and MiglyoI 812~ i8 prepared by stirrin~
and heating at 35-40Cs 2. emulsifiex solution 9.38% by weight phenylsulfonate Ca (70) 4.37% by weight Hoe S 3510 6.25% by weight Hoe S 3474-2 2 ~
~ 10 -35.00% by weight 2-octyldodecanol ~0.00~ by w~ight qMiglyol 812 25O00~ by weigh~ of the described fenbendazole dispersion (l.) are 810wly ad~ed to the emulsifier solution with stirring. This re~ults in a fenben-dazole pour-on formulation which can be adminis~ered satis~actorily.

Example 5 Firstly a 40% ~krength fenbendazole di~persion in water is prepared. Milling tLme 4 hour6, particle si~e reached:
80% < l ~m.

1. fenbendaæole dispersion 40.00% by weight fenbendazole, techn. 9~.8~ pure 4.00% by weight ~enapol LRO paste 56.00~ by weight water 25.0% by weight of the fenbendazole dispersion (1.~
is added to 70.0% by weight of 2 octyldodecanol with stirring; subsequently 5% o$ water are al~o added, ; likewise with stirring.
The result is a 10% strength fenbendazole pour-on formulation which has good pourahility and has very good storage stability.
.
Example 6 The preparation method is as described in Example 5 but the fenbendazole dispersion is only homogenized and not milled 80 that the active ingredient fenbendazole i~ u ed in the particle size as produced:in the preparation~ 50%
o~ the particles ~ 6 ~m.

10% strength fenbendazole pour-on formulation 10.00% by weight fenbendazole, 99.98% pure 1.00% by weight ~Texapon X12 . , . - .
- ~ , . .
- . .: .

. . . . ~ . . .
.

2 ~ 0 2 19.00~ by weight water 70.00% by weight 2-octyldodecanol The formulation is stable on storage and can be administered satisfactorily.

~xample 7 Preparation method as described for E~ample 5. Fenben-dazole particle finene~s 80~ m.

10% strength fenbendazole pour-on formulation :, ~
: 10.00% by weight fenbendazole, 99.98% pure ~:
1.0~% by weig~t ~Te~apon R12 24.00~ by weight water 25,Q0% by weight ~Miglyol 812 40.00% by weight 2-octyldodecanol ~' .
: The result is a pour-on formulation which i~ stable on storage and can be administered sati6factorily.

: Example 8 Preparation method as described for ~xample 5. ~enben-dazole particle finenes~ 50~ ~ 6 ~im.
.:
~; 10% strength fenb~ndazole pour-on formulation : 20 10.00~ by wei~ht fenbendazole, 99.98~ pure 1.00% by weight ~Texapon X12 : 24.00% by weight water 25.00% by weight ~Mlglyol 812 40.00% by weight 2-octyldodecanol The o.rmulation has good storage stability and can be poured satisfactorily.

' ,' ~ .

2 ~

Example 9 Preparation method as descxibed in Example 4. Particle fineness 82% < 1 ~m.

10% strength fenbendazole pour~on formulation 10.00% by wei~ht fenbendazole, 99.98% pure l.Q0~ by weight ~Genapol LRO
39.00% by weight water 15.00% by weight Emulsogen A
35.00% by weight 2-octyldodecanol The result is a pour-on formulation which has good storage stability and good pourabili~y.

Example 10 Preparation method as described for Example 4, but ~Span 60 is dissolved in 2-octyldodecanol at 80-90C. Fenben-dazole particle fineness 82% < 1 ~m.

10% strangth fenbendazole pour-on for~ulation 10.00~ by weight fenbendazole, 99.98~ pure 0.89~ by weigh~ 0Texapon ~12 Zl.33% by weight water 1.00% by weight Span 60 66.78% by weight 2-octyldodecanol The formulation is stable on storag2 and can be administered sat.isfactorily.

Example 11 Fixstly, ~Span ~0 i8 dissolved in 2-octyldodecanol at 80-90C with stirring. Afker cooling to about 50~C, fenbendazole is added; particle ~ize: 5Q% of particles c 6 ~m.

10% ~tr~ngth fenbendazole pour-on formulation .
, - , ~ . .
:

:~ :

2~9~

10.00% by weight fenbenda201e, 99.98~ pure 10.00% ~y weight 0Span 60 80.00% by weight 2-octyldodecanol `
~he mixtuxe i5 homogenized with a high-~peed Ultra Turrax ~ stirrer.

Example 12 For preparation, see Example 11; fenbendazole particle siæe: 50% of particles < 6 ~m.

7.5~ strength fenbendazole pour-on formulation 7.50% by weigh~ feDbendazole, 99.98% pure 10.00~ by weight ~Span 60 82.50% by weight 2-octyldodecanol The mixture is homogenized with a high-~peed Ultxa Turrax stirrer.
.
.: 15 Example 13 Preparation method as described in Exampie 4 and 10.
Fenbendazole pa~ticle ~ize 50% < 5 ~m.

10% strength fenbendazole pour-on formulation 10.00% by weight fenbendazole, 99.98% pure 1.00~ by weigh~ qTexapon ~12 24.00% by weight water 1.00% by weight ~Span 60 64.00% by weight 2~octyldodecanol .
A formulation which can be administered satl~ac-torily is obtained.

Example 14 Alumin~m mono~tearate ia dissolved in 2-octyldodecanol at `
140~150C and kept at this temperature for 30 :minutes .. ~

- 14 - 2~ 2 with stirring. ~fter cooling to About 50C, fenb~ndazole is added and homoganized with a high speed ~ltra-Turra~
stirrer.
Fenbendazvle particle siæe: 50% of particleB ~ 6 ~m.

10% strength fenbendazole pour-on fo.rmulation 10.00~ by weight fenbendazole, ~9.98% pure 1.00% by weight aluminum monosteara~e 89.00~ by weight 2-oc~yldodecano].

A suspension which can easily be poured is obtained.

Example 15 Aluminum monostearate is dissolved in 2-octyldodecanol at 1~0-150C and kept at this temperature for 30 minukes with ætirring. After cooling to about 100C, ~Span 60 is added and, at 50 fenbendazole, both likewise with stirring. Homogenization is ~ubse~uently ¢arried out wlth a high-speed Ultra-~urrax stirrer.
Fenbendazole particle size. 50% o~ particle~ < 6 ~m.
i 10% ~kFength fenbendazole pour-on formulation 10.00% by weight fenbendazole, 99.98~ pure 1.00~ by weight ~Span 60 2.50%:by wei~ht aluminum monostearate :~ 86.50~ by weight 2-octyldodecano1 A formula~ion with good s~orage stability and good pourability i8 obtained.

Example 16 Preparation method as described for Example 15 Fenbendazole paxticle ~ize: 50~ of particles < 6 ~m.

20% strength fenbendazole pour-on formulation 20.00~ by weight fenbendazole~ 99.98% pure .. . .. ..

: : , ~ . . . - - .

. . .

20~9~2 l.00~ by weight ~Span 60 1.50~ by weight aluminum monostearate 77.50% by weight 2-octyldodecanol Example 17 S Preparation method as described or ExEmple 15.
Fenbendazole particle ~ize: 50~ of particles ~ 6 ~m.

11.37~ strength fenb~ndazole pour-on formulation 11.37~ by weight fenbendazole, 99.98~ pure - 100 g/l 1.14% by weight ~Span 60 2.85% by weigh~ aluminum mono~tearate 84.64% by weight 2-octyldodecanol Example 18 8.53~ stxength fenbendazole pour-on formulation 8.53~ by weight fenbendazole, 99.98% pure - 75 g/l 1.14% by weight ~Span ~0 ~, 2.85% by weight aluminum monostearate 87.48% by weight 2-octyldodecanol .
Example 19 ~ ' 5.75% strength fenbendazole pour-on formulation ':
5.75~ by weight fenbendazole, 99.98~ pure - 50 gJl ~:
1.15~ by weight 5pan 60 2.88~ by weight aluminum monosteara~e 90.22% by weight 2-octyldodecanol The products prepared in Examples 16 to 19 have ~ood ~5 storage stability with regard to pha~e separation and con~tancy of ac~ive ingredient content. ~hey can easily be poured and can thsrefore be administered :
as pour-on formulation~ satisfactorily.

, .
. .

2~6~2 Example 20 11.37% strength fenbendazole pour-on formulation 11.37% by weight fenbendazole, 99.98% pure g~l S 2.30% by weight Spa~ 60 1.70% by weight aluminum monostearate 84.62~ by weight 2-octyldodecanol ::
The process i8 as described i~ Example 15. The fenbendazole used is previously milled in a spiral jet mill until 50% of the particle~ have a particle ; size ~ 2.8 ~m.

:~ ~xamples 21-26 ~.
For preparation method, ~ee Example 11 lO.OOg by weight anthelmintic agent ~see Tab. I) I0.00% by weight ~Span 60 80.00% by wei~ht 2-octyldodecanol .
A 5~ strength formulation o~ thiabendazole was prepared:

: 5.0~% by weight thiabendazole 10.00% by wei~ht Qspan 60 85.00~ by weight 2-octyldo~ecanol . ~ , -20S~2 Table I
xample Anthelmin~ic agQnt Formula __.
S 21 O~ibendazole Ia . _ _ _ _ ,_ _ 22 Parbendazole Ia _ ___ _ _ 23 Albendazole a 24 Mebendazole Ia .
Thiabendazole Ib __ _ _ r _ _ _ ;
26 Febantel III

Biological activity The investigations were carried out on cattle which had been arti~icially infected wi~h the economically impor-tant gastrointestinal nematodes of r~minants - Ostertagia ostertagi, Trichostrongylus axei, Trlchostrongylus colubriformis and Cooperia oncophora. The activity was measured by dissection with determination of the worm burden compared with untreated control animal~. The ~5 treatment by pouring on the formulations along the dorsal line of the livestock usually takes place 14 days after infec~ion; at this time the nematodes are still immature and particularly difficult to influence by anthelmintics.

~ he investigations were carried out in accordance with the guidelines of the WAA~P (World Assoaiation for the Advancement of ~eterinary Parasitology; Powers, R.~ et al., Vet. Parasitvl. ~1982) lO, 265-284).

Individual investigations and results are compiled in the following Table II.

.. . .
. ~ , ~ , , .- ~ :

. : - . -. : ~ . - . : : -: :

18 2~5~602 Table I I

~cti~ity oiE feD~endazole in various eour-oDL prsparations against innnature stages of 5~astrointestinal n~matodes of ~attle ___ __ __ ~ hÆ~ ~ 1~ D ~e R~mil~ rq~ c~3e P~l~ d t~[l h~n, ~ ~n~ 0~1s exa~e ~. n~ a~s --`T--~ __ O~p~ I T~a~ C~peru .. __ _ ~ ~_ :olcbdlo=~c oncophora 1 3.75 4 g9 98 lOO 100 7.50 4 72 94 1~0 94 I .
l I
2 3.75 4 ~ 9~ 98 .S~ 4 86 92 94 93 3 3~75 4 98 99 100 g9 l 7.50 4 ~9 lOO 100 100 I as~ ~xm h~l aE I
l t~ csr~:iL gr~> (~) 3922 48~ 132 27 __ === _== _~ r=31: ~= ==_ !
4 7.~0 3 _ _ 100 99,1 750 3 78 g8 100 100 6 7.50 3 91 80 IOD 100 7 7.50 3 36 ~9 99 8 7,50 3 60 20 ~8 100 9 7.50 ~ 99 100 100 100 ¦ ~F ~m~n ~ 2610 26D 1067 1957 I ~ c~ g~p (rF3) I
, ___ __ __ __ _= _ _.==
7.50 7 99 99 Iloo 99 l ~1 7.5~:) 7 91 99 ~9 99 .-a~ ~I h~ 6S73 649 479 2279 ~e ~a C~lp tlE=7) I_c__ _ _== _ _ _ -!
11 ~.0 7 82 92 100 99 7.S 7 70 g3 ~9 98 13 5.0 7 66 B6 100 9t .5 7 91 99 D9 199 ~4 5.0 7 68 97 99 99 7.5 7 84 98 g9 99 S.O 7 > B0 :~ 90 ~ 98 > 98 7,5 7 > ~0 ~ 95 :~ Dl~ > 98 ,a~ ~ h~l aE 5763 1190 ~SI~g 3t67 a~L 9L~p (IF7) __ _~

::

`

19 2~ 2 An indicati~e test was carried out ~o establish the activity of pour-on formulations of fenbendazole, oxiben--dazole, parbendazole, albendazole, mebendazole, thiaben-dazole and febantel (preparation examples 20-25~ on Trichostrongylus oolubriformis in rodents: ~irds (Meriones unguiculatus).

The dosage was in ~ach ca~e 0~2 ml per animal, and 0.4 ml with thiabendazole and additionally 0.1 and O.OS ml with fenbendazole; this volume was dripped onto the ~haven area of the back of the neck of the jirds. ~he possi-bility of intake of active ingredient by licking was prevented l:y khe location of the admini6tration site and the housing of the animals ~ingly.

The re~ult~ ar= li~ted in l!able III.

., , . ...
.

, ~ . . .. .

- ~ , . :
- ~ , . .

xo ~ 6 ~ 2 _ ~ _ _ _ . ; _ _ _ U o o ~ o o o o o o a)d~ O O O ~ O O O ~ O I
W ,, ,, ,, ,, ~ ~ ~ ,, w a _ _ _ _ _ __ _ _ __ ~Um o) ~ ~1 u~ ~ u~ ~n ~ ul u~ u~ a~
~o~ _, _ ~_ _ _. l _. __ :' IQ O O ~ O O O O O O ~`
~O
_ . . _ _ __ _ _ -~. _ _ O O In O O O O C~ O
~ O U~ ~ ~ O o O O ~
: ~ .Y ~ ~, ~ ~ ~ ~ ~ ~
tn~ . . . . . . . . .
~ O ~ 0 ~ ~d .,, ~ ~ o C~ ~ C~ U C~ U O
~ _ ~ _ _ _ _ _ _ __ .~ .~_, o rl ~.~ U~
~ ~ ~ ~ _, o ~ ~ ~ C~
R . ~ . . . D
::1 ~ O O ~ O O O O O O
O ~ 1 ~, E-l c~: _ _ _ __ _ _..
~ S~
. l ~ ~P dP ~P d~ dP d~ dP dP dP
1:~ O O O O O O O O 1~1 ~D ~t _l ~1 ,_~ _1 ~1 ~1 rl t~ ~
I ~ _ _ __ _ _ _._ , _ l ~
I .
a) ,, ,. ~ ~ ~O ~ ,, ~ u ~ P~ ~ ~1 ~1 ~ ~ ~ ~ ~ C`J l I ~1~

__ ~ ~ _ _ O ~ _l 'C
,-~ ~_~ _~ a) o ~1 _~ o ~
l ~ O O O _I _I O O N I rl H ~: N N N C) O N N la 3: ~) H ~U 0 0 0 N _I N ~1 ,a ~:1 a H l ~1 'I:J ~ 1~ 11~ a~ ~a ~ ~ ~:: I
I P~ a a ~ ~ ~ ~ ~ ~ ~ ~ .~ ~:
I ,~ a~ ~ ~ ~ ~ n ~L ~ L ~o~
.

,............ ~ . . . . ~ . .

Claims (10)

1. A preparation which has anthelmintic activity and contains as active ingredient at least one ben-zimidazole, benzothiazole or probenzimidazole with anthelmintic activity in fine-particle dispersion in a penetration-promoting agent.
2. An agent as claimed in claim 1, in which the par-ticles of active ingredient in the dispersion have a particle size of 0.05-30 µm.
3. An agent as claimed in claim 1 or 2, in which the content of active ingredient is 1-60% by weight, preferably 5-20% by weight.
4. An agent as claimed in any of claims 1 to 3, in which are employed a penetration-promoting oil as penetration-promoting agent in a content of 5-95% by weight, together with auxiliaries such as emul-sifiers, wetting agents and/or dispersants in contents of 0.5-30% by weight and antifoam agents in contents of 3-60% by weight.
5. An agent as claimed in any of claims 1 to 4, con-taining the active ingredient fenbendazole.
6. An agent as claimed in any of claims 1 to 5 for transdermal use for the control of helminths in livestock.
7. A process for the preparation of an agent as claimed in any of claims 1 to 6, which comprises converting the fine-particle active ingredient into a suitable administration form.
8. Derivatives of benzimidazoles, benzothiazoles or probenzimidazoles in fine-particle form for trans-dermal use for the control of helminths in livestock.
9. A pour-on process for controlling helminths in livestock, which comprises transdermal use of an agent as claimed in any of claims 1 to 6.
10. The use of an agent as claimed in any of claims 1 to 5 or of a compound as claimed in claim 8 for the transdermal treatment of livestock.
CA002059602A 1991-01-19 1992-01-17 Pour-on formulation for the administration of anthelmintics Abandoned CA2059602A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4101540.1 1991-01-19
DE4101540 1991-01-19

Publications (1)

Publication Number Publication Date
CA2059602A1 true CA2059602A1 (en) 1992-07-20

Family

ID=6423341

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002059602A Abandoned CA2059602A1 (en) 1991-01-19 1992-01-17 Pour-on formulation for the administration of anthelmintics

Country Status (16)

Country Link
EP (1) EP0496316A1 (en)
JP (1) JPH04312504A (en)
AU (1) AU658598B2 (en)
BG (1) BG95755A (en)
BR (1) BR9200163A (en)
CA (1) CA2059602A1 (en)
CS (1) CS14992A3 (en)
FI (1) FI920190A (en)
HU (1) HU208623B (en)
IE (1) IE920150A1 (en)
MX (1) MX9200225A (en)
NO (1) NO920234L (en)
PL (1) PL293227A1 (en)
TR (1) TR27833A (en)
UY (1) UY23355A1 (en)
YU (1) YU2792A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955818B1 (en) 1999-12-02 2005-10-18 Eli Lilly And Company Pour-on formulations
US7772194B2 (en) 2001-09-17 2010-08-10 Eli Lilly And Company Pesticidal formulations

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9207344A (en) * 1991-12-16 1993-07-01 Alza Corp IMPROVED FORMULATIONS THAT HAVE HYDROPHOBIC IMPROVERS OF TRANSDERMIC PENETRATION AND METHOD TO PROVIDE IT.
US5629019A (en) * 1992-02-27 1997-05-13 Alza Corporation Formulations with hydrophobic permeation enhancers
NZ260018A (en) * 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
FR2755824B1 (en) * 1996-11-19 1999-01-08 Virbac Sa GALENIC FORMULATION OF BENZIMIDAZOLES FOR TOPICAL USE, PREPARATION METHOD AND USES THEREOF
CR6243A (en) * 1999-09-20 2008-04-16 Syngenta Participations Ag PESTICIDED FORMULATIONS CONTAINING ALCOXYLATED POLYARYLPHENOLPHOSPHATOESTER TENSOACTIVE AND ALCOXYLATED LIGNOSULPHONATE TENSOACTIVE
WO2001095723A1 (en) * 2000-06-15 2001-12-20 Ssl International Plc Parasiticidal composition
US11160867B2 (en) * 2017-05-11 2021-11-02 Auburn University Anti-protozoal compounds and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA751024B (en) * 1974-03-11 1976-01-28 Lilly Co Eli Control of animal parasites with benzimidazoles
US4018932A (en) * 1975-11-03 1977-04-19 American Cyanamid Company Anthelmintic pour-on formulations for topical use on domestic and farm animals
DE3029426A1 (en) * 1980-08-02 1982-03-11 Bayer Ag, 5090 Leverkusen AGAINST EFFECTIVE POUR-ON FORMULATIONS
DE3045913A1 (en) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen ANTIMYCOTIC AGENTS WITH HIGH ACTIVE SUBSTANCE RELEASE
US4607050A (en) * 1981-10-19 1986-08-19 Wellcome Australia Limited Method of controlling insects and parasites with an aqueous localized pour-on formulation
MA19678A1 (en) * 1982-01-13 1983-10-01 Ciba Geigy Ag ANTI-HELMINTIC AGENTS.
GB8304927D0 (en) * 1983-02-22 1983-03-23 Wellcome Found Pesticidal formulations
IE58016B1 (en) * 1983-08-12 1993-06-16 Ici Australia Ltd Pour-on formulation for the control of parasites
DE3411627A1 (en) * 1984-03-29 1985-10-03 Bayer Ag, 5090 Leverkusen STABILIZED ANTHELMINTIC FORMULATIONS

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6955818B1 (en) 1999-12-02 2005-10-18 Eli Lilly And Company Pour-on formulations
US7772194B2 (en) 2001-09-17 2010-08-10 Eli Lilly And Company Pesticidal formulations
US8048861B2 (en) 2001-09-17 2011-11-01 Eli Lilly And Company Pesticidal formulations

Also Published As

Publication number Publication date
BR9200163A (en) 1992-10-06
PL293227A1 (en) 1992-11-16
BG95755A (en) 1993-12-24
MX9200225A (en) 1992-07-01
AU658598B2 (en) 1995-04-27
HUT62453A (en) 1993-05-28
CS14992A3 (en) 1992-11-18
IE920150A1 (en) 1992-07-29
YU2792A (en) 1995-01-31
EP0496316A1 (en) 1992-07-29
NO920234D0 (en) 1992-01-17
HU9200171D0 (en) 1992-05-28
TR27833A (en) 1995-08-31
NO920234L (en) 1992-07-20
JPH04312504A (en) 1992-11-04
HU208623B (en) 1993-12-28
UY23355A1 (en) 1992-01-23
AU1027792A (en) 1992-08-06
FI920190A (en) 1992-07-20
FI920190A0 (en) 1992-01-16

Similar Documents

Publication Publication Date Title
CS111092A3 (en) Anhydrous transdermal mixture and process for preparing thereof
JP4843269B2 (en) Pour-on formulation for aqueous insecticides
CA2059602A1 (en) Pour-on formulation for the administration of anthelmintics
EP0163598B1 (en) Herbicidal compositions
US20120219634A1 (en) Topical dermal formulations
CN101773129A (en) Compound insecticidal main agent of destruxins and matrine and compound insecticide
MXPA02001504A (en) Ectoparasiticidal aqueous suspension formulations of spinosyns.
DE69528887T2 (en) anthelmintic
TWI314848B (en) Topical parasiticide formulations and methods of treatment
US20060252738A1 (en) Method for preparing and using water-based steroid pheromone compositions
CN102283219A (en) Weeding composition containing florasulam and praflufenethyl
CN102318618A (en) Weeding composition containing florasulam and fluroxypyr
IE840397L (en) Pesticidal pour-on oil formulations
DE69534842T2 (en) NEW PESTICIDE OIL-IN-WATER EMULSION COMPOSITIONS
Hagen The distribution of ascorbic acid between the particulate and non-particulate components of adrenal and liver cells
CN102273465A (en) Weeding composition containing florasulam and clopyralid
US11324695B2 (en) Transdermal solvent system and methods of use
MXPA05005197A (en) Combination product for controlling insect pests.
US5006545A (en) Veterinary compositions against endoparasites containing cypermethrin and albendazole
JPS61268606A (en) Method of keeping away flying insects from livestocks in andout of hut
EP3986129B1 (en) Stable aqueous suspension formulations
HU206621B (en) Process for producing veterinary compositions containing lyotrope liquide christalline benzimidazol derivative
AU2016244321A1 (en) Aqueous insecticidal pour-on formulation
CN102302017A (en) Herbicidal composition containing beflubutamid and flumetsulam
AU2012203102A1 (en) Aqueous insecticidal pour-on formulation

Legal Events

Date Code Title Description
FZDE Discontinued